Document is current
Any future updates will be listed below
-
Authors
Nawas, Afshan Fathima
Solmonson, Ashley
Gao, Boning
DeBerardinis, Ralph J.
Minna, John D.
Conacci-Sorrell, Maralice
Mendelson, Carole R.
-
Funding
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (NCI R35CA220449)
Division of Cancer Prevention, National Cancer Institute (R01CA245548)
Cancer Prevention and Research Institute of Texas (RP220046)
American Cancer Society (724003)
Welch Foundation (I-2058-20210327)
National Institutes of Health (GM145744-01)
NIH (R01-HL050022)
- License Information
-
More Information
Article History
Received: 12 August 2023
Accepted: 2 October 2023
First Online: 20 November 2023
Declarations
:
: RJD is a scientific advisor for Agios Pharmaceuticals, Nirogy Therapeutics, Vida Ventures and Droia Ventures, and a founder and advisor for Atavistik Bioscience. JDM receives royalties from the NIH and UTSW for distribution of human cell lines.
